Trial
NCT06841068
Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Multiple Sclerosis, Progressive
Intervention
Amniotic fluid or placental CD117 stem cells
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-06